About FibroGen Company
FibroGen, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It focuses on the hypoxia-inducible factor and connective tissue growth factor biology to develop medicines for the treatment of anemia, fibrotic disease, and cancer. The company was founded by Thomas B. Neff on September 29, 1993 and is headquartered in San Francisco, CA.
FibroGen/Astellas' EVRENZO (Roxadustat) Making In-Roads in European Market as In-Class Challenger, Akebia/Medice's VAFSEO (Vadadustat), Prepares for Launch in Early 2024.
Exton, Pennsylvania, Dec. 08, 2023 (GLOBE NEWSWIRE) -- EVRENZO made history as the initial hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI) to receive EU approval in August 2021, securing its position by
Analysts Offer Insights on Healthcare Companies: FibroGen (FGEN), BioNTech SE (BNTX) and Sensei Biotherapeutics (SNSE)
FibroGen: Q3 Earnings Snapshot
ColumnsNavigating the Open Interest of Options on 6/27: Palantir Stock Rose Today, But Some Investors Remain Bearish on Its Prospects
The most decrease in the open interest today came to $FibroGen(FGEN.US)$'s put option with a strike price of $10.00 and an e...
Here are the notable stocks with the highest and lowest implied volatility.The $Microvision(MVIS.US)$, $FibroGen(FGEN.US)$, and $Lexicon Pharmaceuticals(LXRX.US)$has the highest implied volatility of all stocks with a market ...
Here are the notable stocks with the highest and lowest implied volatility.
The$PacWest Bancorp(PACW.US)$, $FibroGen(FGEN.US)$, and $Aemetis(AMTX.US)$ has the highest implied volatility of all stocks with a market cap of over 100 million.
William Blair analyst Andy Hsieh upgraded $FibroGen(FGEN.US)$ to Outperform from Market Perform following a deep dive on the potential of pamrevlumab, the company's wholly owned monoclonal antibody against connective tissue growth factor, which is being evaluated in the treatment of idiopathic pulmonary fibrosis, or IPF, locally advanced pancreatic cancer, or LAP...
In reaction to earnings/guidance:
• $GoodRx(GDRX.US)$ +38.5%,$EDGIO(EGIO.US)$ +13.5%,$Lemonade(LMND.US)$ +10.7%,$Desktop Metal(DM.US)$ +8.5%,$ShockWave Medical(SWAV.US)$ +8.2%,$Pubmatic(PUBM.US)$ +8.1%,$Olaplex(OLPX.US)$ +7%,$Vivid Seats(SEAT.US)$ +6.4%,$Noble(NE.US)$ +6.3%,$Aspen Technology(AZPN.US)$ +5.4%,$AAON Inc(AAON.US)$ +5%,$Hudbay Minerals(HBM.US)$ +5%,$Vivint Smart Home(VVNT.US)$ +4.9%,$Vivint Smart Home(VVNT.US)$ +4...